No softening likely in WHO’s antagonism to e-cigs and HnB

It’s no secret that the World Health Organization (WHO) largely rejects the idea of vaping and heat-not-burn (HnB) devices as healthier alternatives to cigarettes. And much of the rhetoric coming out of the eighth Conference of the Parties (COP8) this week underscores that the Geneva-based health authority is unlikely to give next-generation products a role in its anti-tobacco policies any time soon.

Discussions have centered on three WHO Framework Convention on Tobacco Control (FCTC) reports about the progress of e-cigarettes, heated tobacco products and tobacco advertising, which will signal the direction of global tobacco control policies. And the news is not good for the e-cig industry.

Delegates examined one progress report on regulatory and market developments on electronic nicotine delivery systems (ENDS) and another calling for the regulation of HnB product ingredients. They also considered a paper arguing that the depiction in entertainment media of tobacco – including e-cigs and HnB devices – boosts youth smoking.

Read full article
I'm already a subscriber
Author default picture

TobaccoIntelligence

This article was written by one of TobaccoIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual nicotine markets.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation